PharmaBoardroom

Success in Rare Disease Patient Advocacy — What it Takes

After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica Weldon founded Bridge the Gap – SYNGAP Education and…

Françoise Alliot-Launois – Vice President, AFLAR, France

Françoise Alliot-Launois, VP of the French League Against Rheumatism (AFLAR), discusses the issues around bone and joint infections in France,…

Byung Guk Yang – CEO, Daewoong Bio, South Korea

Dr Byung Guk Yang, CEO of Daewoong Bio, explains the challenges the Korean healthcare system is facing and how his experience in the public sector now…

China to Cut Taxes for Rare Disease Drugs

It has been announced by China's State Council that as of March 1st 2019, the government will reduce the VAT on a "first batch" of 21 rare disease…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Greece

All legal aspects surrounding cannabinoid drugs, medicinal cannabis & opioid drugs in Greece. Prepared in association with Calavros Law Firm, a…

Patents and Trademarks: Greece

Key information on patents and trademarks in Greek pharma. Prepared in association with Calavros Law Firm, a leading global law firm, this is an…

Product Liability: Greece

Need the lowdown on product liability in Greek pharma? Read on! Prepared in association with Calavros Law Firm, a leading global law firm, this is an…

Traditional Medicines and OTC Products: Greece

The ins and outs of traditional medicines and OTC products in Greek pharma. Prepared in association with Calavros Law Firm, a leading global law…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…

All about marketing, manufacturing, packaging & labeling and advertising in Greek pharma. Prepared in association with Calavros Law Firm, a…

Preclinical and Clinical Trial Requirements: Greece

The key requirements for conducting pre-clinical and clinical trials in Greece. Prepared in association with Calavros Law Firm, a leading global law…

Regulatory, Pricing and Reimbursement: Greece

A legal intro to the situation regarding regulation, pricing and reimbursement in Greek pharma. Prepared in association with Calavros Law Firm, a…

Finn Søndergaard – CEO, Intsel Chimos, France

Finn Søndergaard, CEO of Intsel Chimos, shares the motivation behind the company’s two recent acquisitions of Diverchim and Centre Lab, and the new…

Tagged with